Click for best price
Malaria Drugs Market Size, Share 2022
Market Analysis and Insights: Global Malaria Drugs Market
The global Malaria Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Malaria Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Malaria Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Malaria Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Malaria Drugs market.
Global Malaria Drugs Scope and Market Size
Malaria Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Malaria Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
By Company
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Kunming Pharmaceutical
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Malaria Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Malaria Drugs, with price, sales, revenue, and global market share of Malaria Drugs from 2019 to 2022.
Chapter 3, the Malaria Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Malaria Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Malaria Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Malaria Drugs.
Chapter 13, 14, and 15, to describe Malaria Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Malaria Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Malaria Drugs Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Malaria Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Malaria Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market by Application
1.3.1 Global Malaria Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Malaria Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Malaria Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Malaria Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Malaria Drugs Sales by Region
2.4.1 Global Malaria Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Malaria Drugs by Region (2023-2028)
2.5 Global Malaria Drugs Revenue by Region
2.5.1 Global Malaria Drugs Revenue by Region (2017-2022)
2.5.2 Global Malaria Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Malaria Drugs Sales by Manufacturers
3.1.1 Global Top Malaria Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Malaria Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Malaria Drugs in 2021
3.2 Global Malaria Drugs Revenue by Manufacturers
3.2.1 Global Malaria Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Malaria Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Malaria Drugs Revenue in 2021
3.3 Global Malaria Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Malaria Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Malaria Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Malaria Drugs Sales by Type
4.1.1 Global Malaria Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Malaria Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Malaria Drugs Sales Market Share by Type (2017-2028)
4.2 Global Malaria Drugs Revenue by Type
4.2.1 Global Malaria Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Malaria Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Malaria Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Malaria Drugs Price by Type
4.3.1 Global Malaria Drugs Price by Type (2017-2022)
4.3.2 Global Malaria Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Malaria Drugs Sales by Application
5.1.1 Global Malaria Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Malaria Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Malaria Drugs Sales Market Share by Application (2017-2028)
5.2 Global Malaria Drugs Revenue by Application
5.2.1 Global Malaria Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Malaria Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Malaria Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Malaria Drugs Price by Application
5.3.1 Global Malaria Drugs Price by Application (2017-2022)
5.3.2 Global Malaria Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Malaria Drugs Market Size by Type
6.1.1 North America Malaria Drugs Sales by Type (2017-2028)
6.1.2 North America Malaria Drugs Revenue by Type (2017-2028)
6.2 North America Malaria Drugs Market Size by Application
6.2.1 North America Malaria Drugs Sales by Application (2017-2028)
6.2.2 North America Malaria Drugs Revenue by Application (2017-2028)
6.3 North America Malaria Drugs Market Size by Country
6.3.1 North America Malaria Drugs Sales by Country (2017-2028)
6.3.2 North America Malaria Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Malaria Drugs Market Size by Type
7.1.1 Europe Malaria Drugs Sales by Type (2017-2028)
7.1.2 Europe Malaria Drugs Revenue by Type (2017-2028)
7.2 Europe Malaria Drugs Market Size by Application
7.2.1 Europe Malaria Drugs Sales by Application (2017-2028)
7.2.2 Europe Malaria Drugs Revenue by Application (2017-2028)
7.3 Europe Malaria Drugs Market Size by Country
7.3.1 Europe Malaria Drugs Sales by Country (2017-2028)
7.3.2 Europe Malaria Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Malaria Drugs Market Size by Type
8.1.1 Asia Pacific Malaria Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Malaria Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Malaria Drugs Market Size by Application
8.2.1 Asia Pacific Malaria Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Malaria Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Malaria Drugs Market Size by Region
8.3.1 Asia Pacific Malaria Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Malaria Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Malaria Drugs Market Size by Type
9.1.1 Latin America Malaria Drugs Sales by Type (2017-2028)
9.1.2 Latin America Malaria Drugs Revenue by Type (2017-2028)
9.2 Latin America Malaria Drugs Market Size by Application
9.2.1 Latin America Malaria Drugs Sales by Application (2017-2028)
9.2.2 Latin America Malaria Drugs Revenue by Application (2017-2028)
9.3 Latin America Malaria Drugs Market Size by Country
9.3.1 Latin America Malaria Drugs Sales by Country (2017-2028)
9.3.2 Latin America Malaria Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Malaria Drugs Market Size by Type
10.1.1 Middle East and Africa Malaria Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Malaria Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Malaria Drugs Market Size by Application
10.2.1 Middle East and Africa Malaria Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Malaria Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Malaria Drugs Market Size by Country
10.3.1 Middle East and Africa Malaria Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Malaria Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Overview
11.1.3 Cipla Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cipla Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cipla Recent Developments
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Corporation Information
11.2.2 Guilin Pharmaceutical Overview
11.2.3 Guilin Pharmaceutical Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Guilin Pharmaceutical Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Guilin Pharmaceutical Recent Developments
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Corporation Information
11.3.2 IPCA Laboratories Overview
11.3.3 IPCA Laboratories Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 IPCA Laboratories Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 IPCA Laboratories Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Mylan Labs
11.5.1 Mylan Labs Corporation Information
11.5.2 Mylan Labs Overview
11.5.3 Mylan Labs Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Labs Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Labs Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Overview
11.8.3 Sanofi Aventis Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Aventis Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Aventis Recent Developments
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Overview
11.9.3 Ajanta Pharma Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ajanta Pharma Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ajanta Pharma Recent Developments
11.10 Kunming Pharmaceutical
11.10.1 Kunming Pharmaceutical Corporation Information
11.10.2 Kunming Pharmaceutical Overview
11.10.3 Kunming Pharmaceutical Malaria Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Kunming Pharmaceutical Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kunming Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Malaria Drugs Industry Chain Analysis
12.2 Malaria Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Malaria Drugs Production Mode & Process
12.4 Malaria Drugs Sales and Marketing
12.4.1 Malaria Drugs Sales Channels
12.4.2 Malaria Drugs Distributors
12.5 Malaria Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Malaria Drugs Industry Trends
13.2 Malaria Drugs Market Drivers
13.3 Malaria Drugs Market Challenges
13.4 Malaria Drugs Market Restraints
14 Key Findings in The Global Malaria Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Malaria Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Aryl Aminoalcohol Compounds
Table 3. Major Manufacturers of Antifolate Compounds
Table 4. Major Manufacturers of Artemisinin Compounds
Table 5. Global Malaria Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Malaria Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Malaria Drugs Sales by Region (2017-2022) & (K Units)
Table 8. Global Malaria Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Malaria Drugs Sales by Region (2023-2028) & (K Units)
Table 10. Global Malaria Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Malaria Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Malaria Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Malaria Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Malaria Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Malaria Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Malaria Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Malaria Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Malaria Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Malaria Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Malaria Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Malaria Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Drugs as of 2021)
Table 22. Malaria Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Malaria Drugs Product Offered
Table 24. Date of Manufacturers Enter into Malaria Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Malaria Drugs Sales by Type (2017-2022) & (K Units)
Table 27. Global Malaria Drugs Sales by Type (2023-2028) & (K Units)
Table 28. Global Malaria Drugs Sales Share by Type (2017-2022)
Table 29. Global Malaria Drugs Sales Share by Type (2023-2028)
Table 30. Global Malaria Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Malaria Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Malaria Drugs Revenue Share by Type (2017-2022)
Table 33. Global Malaria Drugs Revenue Share by Type (2023-2028)
Table 34. Malaria Drugs Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Malaria Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Malaria Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Malaria Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Malaria Drugs Sales Share by Application (2017-2022)
Table 39. Global Malaria Drugs Sales Share by Application (2023-2028)
Table 40. Global Malaria Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Malaria Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Malaria Drugs Revenue Share by Application (2017-2022)
Table 43. Global Malaria Drugs Revenue Share by Application (2023-2028)
Table 44. Malaria Drugs Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Malaria Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Malaria Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Malaria Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Malaria Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Malaria Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Malaria Drugs Sales by Application (2017-2022) & (K Units)
Table 51. North America Malaria Drugs Sales by Application (2023-2028) & (K Units)
Table 52. North America Malaria Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Malaria Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Malaria Drugs Sales by Country (2017-2022) & (K Units)
Table 55. North America Malaria Drugs Sales by Country (2023-2028) & (K Units)
Table 56. North America Malaria Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Malaria Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Malaria Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Malaria Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Malaria Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Malaria Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Malaria Drugs Sales by Application (2017-2022) & (K Units)
Table 63. Europe Malaria Drugs Sales by Application (2023-2028) & (K Units)
Table 64. Europe Malaria Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Malaria Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Malaria Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Malaria Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Malaria Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Malaria Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Malaria Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Malaria Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Malaria Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Malaria Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Malaria Drugs Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Malaria Drugs Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Malaria Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Malaria Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Malaria Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Malaria Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Malaria Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Malaria Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Malaria Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Malaria Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Malaria Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Malaria Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Malaria Drugs Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Malaria Drugs Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Malaria Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Malaria Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Malaria Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Malaria Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Malaria Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Malaria Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Malaria Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Malaria Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Malaria Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Malaria Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Malaria Drugs Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Malaria Drugs Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Malaria Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Malaria Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Malaria Drugs Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Malaria Drugs Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Malaria Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Malaria Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Cipla Corporation Information
Table 107. Cipla Description and Major Businesses
Table 108. Cipla Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Cipla Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Cipla Recent Developments
Table 111. Guilin Pharmaceutical Corporation Information
Table 112. Guilin Pharmaceutical Description and Major Businesses
Table 113. Guilin Pharmaceutical Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Guilin Pharmaceutical Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Guilin Pharmaceutical Recent Developments
Table 116. IPCA Laboratories Corporation Information
Table 117. IPCA Laboratories Description and Major Businesses
Table 118. IPCA Laboratories Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. IPCA Laboratories Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. IPCA Laboratories Recent Developments
Table 121. GlaxoSmithKline Corporation Information
Table 122. GlaxoSmithKline Description and Major Businesses
Table 123. GlaxoSmithKline Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. GlaxoSmithKline Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. GlaxoSmithKline Recent Developments
Table 126. Mylan Labs Corporation Information
Table 127. Mylan Labs Description and Major Businesses
Table 128. Mylan Labs Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Mylan Labs Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Mylan Labs Recent Developments
Table 131. Roche Corporation Information
Table 132. Roche Description and Major Businesses
Table 133. Roche Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Roche Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Roche Recent Developments
Table 136. Novartis Corporation Information
Table 137. Novartis Description and Major Businesses
Table 138. Novartis Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Novartis Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Novartis Recent Developments
Table 141. Sanofi Aventis Corporation Information
Table 142. Sanofi Aventis Description and Major Businesses
Table 143. Sanofi Aventis Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Sanofi Aventis Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sanofi Aventis Recent Developments
Table 146. Ajanta Pharma Corporation Information
Table 147. Ajanta Pharma Description and Major Businesses
Table 148. Ajanta Pharma Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Ajanta Pharma Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Ajanta Pharma Recent Developments
Table 151. Kunming Pharmaceutical Corporation Information
Table 152. Kunming Pharmaceutical Description and Major Businesses
Table 153. Kunming Pharmaceutical Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. Kunming Pharmaceutical Malaria Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Kunming Pharmaceutical Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Malaria Drugs Distributors List
Table 159. Malaria Drugs Customers List
Table 160. Malaria Drugs Market Trends
Table 161. Malaria Drugs Market Drivers
Table 162. Malaria Drugs Market Challenges
Table 163. Malaria Drugs Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Malaria Drugs Product Picture
Figure 3. Global Malaria Drugs Market Share by Type in 2021 & 2028
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Malaria Drugs Market Share by Application in 2021 & 2028
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Other
Figure 10. Malaria Drugs Report Years Considered
Figure 11. Global Malaria Drugs Sales 2017-2028 (K Units)
Figure 12. Global Malaria Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Malaria Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global Malaria Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Malaria Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global Malaria Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America Malaria Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. North America Malaria Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Malaria Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Malaria Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Malaria Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Malaria Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Malaria Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Malaria Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Malaria Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Malaria Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Malaria Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Malaria Drugs in the World: Market Share by Malaria Drugs Revenue in 2021
Figure 29. Global Malaria Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Malaria Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Malaria Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Malaria Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Malaria Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America Malaria Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America Malaria Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America Malaria Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Malaria Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Malaria Drugs Sales Share by Country (2017-2028)
Figure 39. North America Malaria Drugs Revenue Share by Country (2017-2028)
Figure 40. U.S. Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Malaria Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Malaria Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Malaria Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Malaria Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Malaria Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Malaria Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Malaria Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Malaria Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Malaria Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Malaria Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Malaria Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Malaria Drugs Revenue Share by Region (2017-2028)
Figure 59. China Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Malaria Drugs Sales Market Share by Type (2017-2028)
Figure 70. Latin America Malaria Drugs Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Malaria Drugs Sales Market Share by Application (2017-2028)
Figure 72. Latin America Malaria Drugs Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Malaria Drugs Sales Share by Country (2017-2028)
Figure 74. Latin America Malaria Drugs Revenue Share by Country (2017-2028)
Figure 75. Mexico Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Malaria Drugs Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Malaria Drugs Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Malaria Drugs Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Malaria Drugs Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Malaria Drugs Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Malaria Drugs Revenue Share by Country (2017-2028)
Figure 84. Turkey Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Malaria Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Malaria Drugs Value Chain
Figure 88. Malaria Drugs Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
